نتایج جستجو برای: rara positive apl

تعداد نتایج: 662831  

Journal: :Blood 2000
D Sainty V Liso A Cantù-Rajnoldi D Head M J Mozziconacci C Arnoulet L Benattar S Fenu M Mancini E Duchayne F X Mahon N Gutierrez F Birg A Biondi D Grimwade M Lafage-Pochitaloff A Hagemeijer G Flandrin

Acute promyelocytic leukemia (APL) is typified by the t(15;17) translocation, which leads to the formation of the PML/RARA fusion gene and predicts a beneficial response to retinoids. However, approximately 10% of all APL cases lack the classic t(15;17). This group includes (1) cases with cryptic PML/RARA gene rearrangements and t(5;17) that leads to the NPM/RARA fusion gene, which are retinoid...

Journal: :Blood 2010
Ashley N Mays Neil Osheroff Yuanyuan Xiao Joseph L Wiemels Carolyn A Felix Jo Ann W Byl Kandeepan Saravanamuttu Andrew Peniket Robert Corser Cherry Chang Christine Hoyle Anne N Parker Syed K Hasan Francesco Lo-Coco Ellen Solomon David Grimwade

Therapy-related acute promyelocytic leukemia (t-APL) with t(15;17)(q22;q21) involving the PML and RARA genes is associated with exposure to agents targeting topoisomerase II (topoII), particularly mitoxantrone and epirubicin. We previously have shown that mitoxantrone preferentially induces topoII-mediated DNA damage in a "hotspot region" within PML intron 6. To investigate mechanisms underlyin...

2008
Sumit J. Shah Steven Blumen Ian Pitha-Rowe Sutisak Kitareewan Sarah J. Freemantle Qing Feng Ethan Dmitrovsky

Acute promyelocytic leukemia (APL) is characterized by expression of promyelocytic leukemia (PML)/retinoic acid (RA) receptor A (RARA) protein and all-trans-RA-mediated clinical remissions. RA treatment can confer PML/RARA degradation, overcoming dominant-negative effects of this oncogenic protein. The present study uncovered independent retinoid degradation mechanisms, targeting different doma...

Ardeshir Ghavamzadeh, Hossein Mozdarani, Kamran Alimoghaddam, Marjan Hajhashemi, Marjan Yaghmaie, Mozaffar Aznab, Seyed H. Ghaffari,

Background: The secondary genetic changes other than the promyelocytic leukemia-retinoic acid receptor (PML-RARA) fusion gene may contribute to the acute promyelocytic leukemogenesis. Chromosomal alterations and mutation of FLT3 (FMS-like tyrosine kinase 3) tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia. However, the prognostic significance of FLT3 mutat...

2012
Lukas D. Wartman John S. Welch Geoffrey L. Uy Jeffery M. Klco Tamara Lamprecht Nobish Varghese Rakesh Nagarajan Timothy J. Ley

Because PML-RARA-induced acute promyelocytic leukemia (APL) is a morphologically differentiated leukemia, many groups have speculated about whether its leukemic cell of origin is a committed myeloid precursor (e.g. a promyelocyte) versus an hematopoietic stem/progenitor cell (HSPC). We originally targeted PML-RARA expression with CTSG regulatory elements, based on the early observation that thi...

2002
Shuo Dong David J. Tweardy

Signal transducer and activator of transcription (STAT) 5b-retinoic acid receptor (RAR) a is the fifth fusion protein identified in acute promyelocytic leukemia (APL). Initially described in a patient with all-trans retinoic acid (ATRA)–unresponsive disease, STAT5b-RARa resulted from an interstitial deletion on chromosome 17. To determine the molecular mechanisms of myeloid leukemogenesis and m...

Journal: :international journal of hematology-oncology and stem cell research 0
marjan yaghmaie medical genetics department, faculty of medical sciences, tarbiat modares university, tehran, iran hossein mozdarani medical genetics department, faculty of medical sciences, tarbiat modares university, tehran, iran kamran alimoghaddam hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran ardeshir ghavamzadeh hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran seyed hamiollah ghaffari hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran

introduction: the secondary genetic changes other than the pml-rara fusion gene may contribute to the acute promyelocytic leukemogenesis. chromosomal alterations and mutation of flt3 tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia (aml). however, the prognostic significance of flt3 mutations in acute promyelocytic leukemia (apl) is not firmly established....

2017
Stephen E Langabeer Lisa Preston Johanna Kelly Matt Goodyer Ezzat Elhassadi Amjad Hayat

Several variant RARA translocations have been reported in acute promyelocytic leukemia (APL) of which the t(11;17)(q23;q21), which results in a ZBTB16-RARA fusion, is the most widely identified and is largely resistant to therapy with all-trans retinoic acid (ATRA). The clinical course together with the cytogenetic and molecular characterization of a case of ATRA-unresponsive ZBTB16-RARA APL is...

ژورنال: :پیاورد سلامت 0
محمد عراقی m araghi master of sciences , school of allied health sciences , tehran university of medical sciences , tehran , iranکارشناس ارشد هماتولوژی و انتقال خون دانشکده پیراپزشکی دانشگاه علوم پزشکی تهران کامران علی مقدم k alimoghadam associate professor , hematology – oncology and bmt research center , tehran university of medical sciences , tehran , iranدانشیار مرکز تحقیقات خون و انکولوژی و پیوند مغز استخوان دانشگاه علوم پزشکی تهران ناهید عین اللهی n einollahi assistant professor , school of allied health sciences , tehran university of medical sciences , tehran , iranاستادیار دانشکده پیراپزشکی دانشگاه علوم پزشکی تهران بهرام چاردولی b chardooli master of sciences , hematology – oncology and bmt research center , tehran university of medical sciences , tehran , iranکارشناس ارشد مرکز تحقیقات خون ، انکولوژی و پیوند مغز استخوان دانشگاه علوم پزشکی تهران حمید رضا رحیمی hr rahimi master of sciences , hematology – oncology and bmt research center , tehran university of medical sciences , tehran , iranکارشناس ارشد ایمونولوژی مرکز تحقیقات خون ، انکولوژی و پیوند مغز استخوان دانشگاه علوم پزشکی تهران شهربانو رستمی sh rostami master of sciences , hematology – oncology and bmt research center , tehran university of medical sciences , tehran , iranکارشناس ارشد هماتولوژی و انتقال خون مرکز تحقیقات خون ، انکولوژی و پیوند مغز استخوان دانشگاه علوم پزشکی تهران اردشیر قوام زاده

زمینه و هدف: لوسمی پرومیلوسیتی حاد(apl) با جابجایی کروموزومی (15:17) t ( الحاق گر ژن های pml و rara)، همراه است. شواهد سیتوژنتیک و مولکولی این جابجایی در 90 تا100درصد بیماران با ریخت شناسی apl شناسایی شده است. این بیماری به صورت ویژه ای  به درمان با atra حساس بوده و به شیمی درمانی رایج بخوبی پاسخ می دهد. ناهنجاری t(1117)(q23q21)  همراه با بازآرایی p‏lzf-rara  شایع ترین جابجایی جایگزین است که در...

Journal: :Haematologica 2005
Jessica L Pollock Andrew A Lane Kelly Schrimpf Timothy J Ley

BACKGROUND AND OBJECTIVES In this study, we tested whether transgenic murine acute promyelocytic leukemia (APL) cells can be recognized and cleared by adaptive immune responses and/or vaccination strategies. DESIGN AND METHODS Immunocompetent and SCID mice were examined for their ability to survive a challenge of APL cells. We also vaccinated immunocompetent mice with DNA vaccines encoding va...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید